Everstone Group Wins Four Back to Back Prestigious Awards

Wins ‘Firm of The Year – India’ and ‘Mid-Market Firm of The Year – Asia’ by Private Equity International, Wins ‘Indian Fund Manager of the Year’ by VC Circle and Wins ‘Firm of the Year in India’ (Real Estate – IndoSpace) by PERE

Mumbai, March 02, 2020 – The prestigious ‘Private Equity International’ (PEI) has named Everstone Group ‘Firm of the Year – India’ and ‘Mid-Market Firm of the Year – Asia’ at PEI Awards 2019. The Group has won these awards for the eighth and the third time respectively since 2011.

The PEI Awards are the largest and most respected awards in the global private equity industry. With multiple categories for selection, voters have the chance to vote for categories across Global awards, EMEA awards, North America awards, Asia-Pacific awards and Secondaries awards.

Additionally, IndoSpace, the real estate arm of Everstone and India’s largest developer of Grade A industrial real estate and logistics parks has been named as the ‘Firm of the Year – India’ by ‘PERE’, the real estate arm of PEI, at PERE Awards 2019.

PERE is the leading publication for the world’s private real estate markets. Its annual awards recognize the industry’s most elite people, firms and deals across a variety of distinct categories. The winner of each category is determined by industry participants through a highly controlled voting system. This year, more than 100,000 votes were cast for the PERE awards.

Everstone Capital also won the ‘Indian Fund Manager of the Year’ at the recently held VC Circle Awards 2020. The annual VCCircle awards felicitates Private Equity and Venture Capital-backed companies in key sectors as well as investment funds, law firms and investment bankers.

Sameer Sain, Co-Founder and CEO, Everstone Group, said “We are delighted to win these four extremely coveted awards. We are thankful to our investors and partners for their vote of confidence as well as to our incredibly talented team. We look forward to continue the good work and set new benchmarks of excellence in the coming years.”

The PEI and PERE awards follow a rigorous nomination and global voting process that involves investors, peers and subscribers from the private equity and real estate industry respectively.

About Everstone Group

Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com and LinkedIn

READ MORE

Everstone to Partner with Brookfield for an investment In IndoStar

Mumbai Friday, January 31, 2020 – The Everstone Group (Everstone), a leading private equity and real estate investor, today announced that it has entered into an agreement whereby Brookfield Business Partners, together with its institutional partners (collectively “Brookfield”) will, upon closing of the transaction, invest INR 1,450 crore in IndoStar Capital Finance Limited (IndoStar) through a combination of subscription to securities and purchase of shares from IndoStar Capital Mauritius and mandatory tender offer, and seek to acquire 40% interest in the business, depending upon the subscription to the mandatory tender offer.

The overall investment will comprise a combination of primary investment in equity shares and compulsorily convertible preference shares of INR 1,225 crore along with a secondary purchase of shares from IndoStar Capital Mauritius. Brookfield will also become a co-promoter in IndoStar and nominate two board members. R. Sridhar will continue to lead the company in his role as Vice Chairman and CEO, IndoStar.

The fresh investment by Brookfield will support the continued growth of IndoStar’s retail business.

Speaking on the investment, Dhanpal Jhaveri, Chairman, IndoStar and Vice Chairman, Everstone India said “We are delighted to partner with a reputable global investor such as Brookfield and welcome them to the IndoStar family. We see opportunities to continue delivering substantial value to IndoStar’s customers, employees and investors. We have built a top-quality business in IndoStar and are excited for its next phase of growth.”

Aditya Joshi, Senior Vice President, Brookfield, said, “We believe in the long-term secular growth runway of the Indian retail financial services sector. IndoStar has an experienced management team and a strong position in attractive and growing retail lending segments. We look forward to partnering with Everstone and the IndoStar management team to further scale the business.” IndoStar Capital Mauritius continues to be the promoter and an active shareholder in IndoStar which it built from the ground up since 2011. IndoStar has assets under management of INR 10,600 crore and offers a wide range of loans to nearly 60,000 customers. The investment remains subject to receipt of regulatory approvals and satisfaction of other closing conditions. Nomura served as the exclusive financial advisor. S&R Associates, AZB & Partners and Cyril Amarchand Mangaldas acted as legal counsel for Everstone, Brookfield and IndoStar respectively.

About the Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5
billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant
resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and
Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience
and skills. For more information, visit www.everstonecapital.com and follow us on LinkedIn

About Brookfield Business Partners
Brookfield Business Partners is a business services and industrials company focused on owning and operating
high-quality businesses that benefit from barriers to entry and/or low production costs. Brookfield Business
Partners is the flagship listed business services and industrials company of Brookfield Asset Management, a
global alternative asset manager with more than $500 billion of assets under management. For more
information, visit www.brookfield.com

About IndoStar Captial Finance Limited
IndoStar is a non-banking finance company (NBFC) registered with the Reserve Bank of India as a systemically
important non-deposit taking company. Promoted by Everstone Group, IndoStar is a professionally managed
and institutionally owned organization which is engaged in providing structured term financing solutions to
corporates, used and new commercial vehicle financing for transporters, and loans to SME borrowers,
affordable Home Finance through the wholly-owned subsidiary IndoStar Home Finance Private Limited.
IndoStar has assets under management of Rs. 106 billion and offers a wide range of loans to nearly 60,000
customers. For more information, visit www.indostarcapital.com

READ MORE

Slayback Pharma announces investment of $50 million by The Everstone Group

Mumbai/New Jersey/Singapore, January 06, 2020 – Slayback Pharma LLC (“Slayback”) today announced an agreement with The Everstone Group (“Everstone”) to invest up to US$50 million in Series B funding. The new capital will be used to expand and accelerate further Slayback’s already rich and differentiated pipeline of complex generic and specialty pharmaceutical products. In addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback’s Board of Directors. Everstone joins existing institutional investor KKR, who first invested in Slayback with a US$60 million commitment in December 2016.

Ajay Singh, Founder & CEO of Slayback, said: “We are delighted to partner with Everstone in our quest for smart solutions to complex pharmaceutical challenges. Their experience in investing in and building pharmaceutical businesses with a focus on regulated markets will help turbo-charge our growth pipeline of complex and specialty products. We are especially thrilled to welcome Arjun and Puncham to our board.”

Sameer Sain, Co-Founder & CEO of Everstone, said: “Slayback’s expertise in complex generics fits well with our healthcare investment strategy. Slayback joins our list of notable healthcare investments, and we are optimistic about the commercial potential of Slayback’s highly differentiated pipeline of complex generics developed by its strong R&D team in India. We are excited to become a part of Slayback as it is poised for its next wave of growth.”

Ali Satvat, Co-Head of KKR’s Health Care investment team and member of Slayback’s Board of Directors, said: “Since our initial investment in Slayback, the growth that the Company has achieved in its portfolio and pipeline has been rather remarkable. As we look ahead to the next chapter of Slayback’s growth, we are delighted to be working with Everstone to help scale the Company and its differentiated products even further.”

About Slayback
Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and Europe. Since its inception in 2011, Slayback has demonstrated a spectacular track record of numerous sole first-to-file ANDAs, 505(b)(2)s and complex generic filings, approvals and launches. In the past year, Slayback’s ANDA for Hydroxyprogesterone 5 ml vial was the first generic ANDA to be approved and launched in the U.S., and Slayback continues to hold the largest market share. Previously, Slayback has shown its excellent execution skills through the approval and launch of numerous difficult products such as Propofol Injectable Emulsion.

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), Mauritius, London and New York, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

READ MORE

The Everstone Group Names Alok Oberoi as Executive Chairman

Mumbai/Singapore, November 27, 2019 – The Everstone Group, India and South East Asia’s premier Private Equity and Real Estate investor, has named Alok Oberoi as Executive Chairman effective January 1, 2020.

Alok spent over 14 years at Goldman Sachs where he was named as a General Partner in 1996. Amongst many businesses, Alok led Goldman Sachs’ Wealth Management business in Asia and subsequently also ran it Internationally. Post Goldman Sachs, Alok was the Co-Founder and Chairman of ACPI, a multi-family office and wealth management business based in London which he has since exited. Alok has also been a shareholder of Everstone since its inception and has served as a Director as well as an active member of its various Investment Committees. Alok has a Master’s degree in Business Administration as well as a Bachelor’s degree from Cornell University.

In his new role as Executive Chairman, Alok will work very closely with Sameer Sain, Co-Founder & CEO of The Everstone Group. He will drive the Group’s overall strategy and governance as well as bring his vast network and investment experience to bear on investments and exits across asset classes and geographies. He will continue to serve on the investment committees and in order to fulfil his new role and responsibilities, he will also relocate to Singapore.

Commenting on the appointment, Sameer Sain, Co-Founder & CEO, The Everstone Group said: “On behalf of my Co-Founder Atul Kapur and the partners of Everstone, I am delighted that Alok is transitioning from a non-executive to a full-time executive and leadership role. I have had the privilege of knowing him and working with him at Goldman Sachs as well as Everstone for over 25 years. We are proud to have him as our Executive Chairman and look forward to a great journey ahead.”

Alok Oberoi, Executive Chairman, The Everstone Group added: “I have been actively associated with Everstone since it’s very inception and so this new role seems like a natural progression. I am excited to work with Sameer, Atul and the rest of my Everstone family and look forward to building on the exceptional business they have already created.”

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), Mauritius, London and New York, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

READ MORE

Everstone Capital makes another senior hire

Mumbai, October 04, 2019 –Everstone Capital today announced the appointment of Vibhor Kumar Talreja as a Managing Director. He will lead the financial services sector amongst other responsibilities.

Prior to joining Everstone, Vibhor was with Temasek India for over 12 years. As a Director at Temasek, he led decision making on investments & divestments of over $2 billion each across both private & public transactions. Amongst other sectors, Vibhor has actively covered Financial Services, Industrials/Consumer, Real Estate & Telecom. He has also worked with renowned global and Indian companies such as JM Morgan Stanley and Tata Administrative Services.

Vibhor is an alumnus of IIT Kanpur & IIM Bangalore and will be based in Mumbai.

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), Mauritius, London and New York, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

READ MORE

Everstone-backed Everlife appoints Raman Gandotra as Chief Executive Officer

Singapore/Mumbai, September 11, 2019 – Everlife Holdings Pte. Ltd. (Everlife), a leading distributor and manufacturer of medical and laboratory equipment and devices in Asia—announced today the appointment of Raman Gandotra as its new CEO. Based out of Singapore, Raman will lead the platform through its next stage of growth which will focus on continuing to deliver superior performance for its principals, further strengthening the company’s position in core markets and priority segments through acquisitions and realising synergies across our portfolio of companies.

Raman brings with him over 25 years of experience, with a proven track record in building effective teams and driving growth for leading industry players in the pharmaceutical and medical devices sectors.

Prior to joining Everlife, Raman was leading the India and South-East Asia business of Smith & Nephew, a global leader in surgical equipment, orthopaedics and wound care. Raman and his team built strong growth, sustainably gaining shares across businesses in five years while increasing margins. He led disciplined customer segmentation and targeting, driving operational excellence initiatives across countries, creating effective engagement strategies with distribution partners and continuing to introduce innovative products that improve healthcare outcomes for patients. Prior to Smith & Nephew, Raman held leadership roles in India and South-East Asia at Baxter and Allergan.

“Raman is very well-positioned to take the helm of Everlife, given his experience, skills and his action-oriented leadership style. The Board and I have strong confidence in his ability to identify and deliver on opportunities to drive growth, strengthen our operational cadence and cement our position in the region as a leader in our space.” said Arjun Oberoi, Vice Chairman of the Board, Everlife and Managing Director, Everstone Capital.

“I am excited to join Everlife at this pivotal point in the company’s evolution. Everlife has already emerged as a leader in the laboratory, medical equipment and devices space in Asia. I look forward to leading the next phase of Everlife’s journey through its expansion in new geographies and product segments and adopting new tools and technologies to bring superior value to our customers.” said Raman Gandotra on joining the Everlife team.

Everlife has investments in CPC Diagnostics, an India based manufacturer and marketer of in-vitro diagnostic products; Malaysia-based Chemopharm Group, a leading provider of products and solutions to laboratory, research and medical facilities in South-East Asia; DV Medika Group, manufacturer and distributor of one of Indonesia’s top brands of hospital furniture and other imported medical equipment and supplies; and Singapore-based Bio-REV Pte. Ltd., which specializes in distribution of reagents, media and consumables to the Life Sciences industry.

About Everlife Holdings Pte Ltd
Everlife Holdings Pte. Ltd. is a buy-and-build platform aimed to provide complete solutions for the healthcare and research industries in South East Asia and India. As part of the Everstone Group, Everlife invests in manufacturers and distributors in the region covering key strategic segments including in-vitro diagnostics, medical diagnostics, critical care equipment, implants and consumables. Cure Capital is a minority investor in Everlife. Everlife’s portfolio companies represent more than 200 principals and its more than 600 employees operate in seven countries. For more information, visit www.everlifeasia.com.
LinkedIn

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

READ MORE

Everstone Group makes significant investment in Translumina

Mumbai, August 27, 2019 – The Everstone Group has made a significant investment to acquire a stake in Translumina. The proceeds from the investment will help Translumina accelerate the company’s growth and scale its operations globally.

Founded in Hechingen, Germany, Translumina is a leading global manufacturer and distributor of cardiac stents and cardiovascular medical devices. Translumina’s technologies were developed in collaboration with the German Heart Centre and are endorsed by the European Society of Cardiology. Translumina combines the best of German technology, intellectual property and high-quality standards with Indian capabilities of manufacturing innovative products at affordable prices.

Translumina benefits from end-to-end development and manufacturing capabilities of stent delivery systems in India and Germany. The company distributes its products in over 30 countries across Europe, Asia, Latin America and Middle East. Everstone’s partnership will help the Company to acquire global assets, augment the company’s research and development efforts, bolster its India manufacturing capabilities and enhance Translumina’s distribution ecosystem.

“We are excited to partner with Everstone group who possess the best expertise in the market today to guide young companies to become large multinationals. Everstone’s sectoral and international experience will help Translumina achieve its’ global ambition by strengthening our organization and systems while retaining our agility and entrepreneurial spirit to create strong footprints in healthcare market” said Gurmit Singh Chugh, Chairman of Translumina.

“Translumina is extremely well positioned to emerge as a global leader in stents and cardiovascular technologies at highly affordable prices. Everstone’s expertise in healthcare will help unlock the company’s full potential by scaling manufacturing, strengthening its global distribution and driving new product development” said Arjun Oberoi, Managing Director, Everstone Group.

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com

About Translumina
Translumina is a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology and minimally invasive surgery. It’s flagship products, YUKON® Choice PC, YUKON® Choice Flex, YUKON® Chrome PC and VIVO ESAR represent the 3rd generation drug eluting stents systems. Translumina is the only company in the world that has published 10-year safety and efficacy data for its Yukon Choice PC stent in a head-to-head study against Xience, a market-leading stent from Abbott, as per the ISAR-TEST 4 study presented at the 2018 American Heart Association meeting. In addition, the company markets a wide range of cardiovascular devices including coronary angioplasty balloons, structural heart disease products and cardiac assist devices. For more information, visit www.translumina.in and www.translumina.de
LinkedIn

READ MORE

Everstone Group bolsters its US presence

Mumbai, April 24, 2019 – The Everstone Group is pleased to announce the appointment of Suneel Kaji as a Managing Director in New York. He will work on developing strategic relationships with large institutional investors, sponsors, corporates and service providers. This will enhance the firm’s private markets business in India and Southeast Asia through stronger investor connects, building an eco-system for cross-border expansions and exit options for portfolio companies.

Suneel Kaji joins Everstone from University of Texas Investment Management Company (“UTIMCO”), where he was a senior member of their private investments team. Kaji has over two decades of private markets experience in control and structured investing across the US and Asia.

“We continue to strengthen our team with leaders who have deep experience across asset classes and geographies. Suneel brings a wealth of international investing and banking experience and will add tremendous value to the group.” said Sameer Sain, CEO, The Everstone Group

“Everstone is a leading investor with deep operational ability to successfully build and grow diversified businesses. I am excited to join the team and contribute to Everstone’s growth and success.” said Suneel Kaji, Managing Director, Everstone Capital.

Prior to UTIMCO, Kaji had been a Founding Partner of Accordion Capital, the principal co-investment affiliate of Accordion Partners, a New York-based private equity consultancy. He previously worked with the private equity teams at DLJ in New York and Hong Kong and at Goldman Sachs in New York. Kaji started his career in investment banking at Salomon Brothers in M&A and Leveraged Finance. He received his MBA from the Stanford Graduate School of Business, and his Bachelor of Science in Economics, magna cum laude, from the Wharton School of the University of Pennsylvania.

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

READ MORE

Everstone Group to acquire controlling stake in Sahyadri Hospitals

Mumbai, April 07, 2019 – The Everstone Group(Everstone), has signed an agreement to acquire a controlling stake in Sahyadri Hospitals Limited(Sahyadri), the largest hospital chain in Maharashtra. The combination of primary and secondary capital outlay is expected to increase the bed-count significantly in next five years.

Founded in 1994, Pune headquartered Sahyadri Hospitals currently operates 5 tertiary care and 3 secondary care hospitals with 750 beds across Pune (Deccan Gymkhana, Nagar Road, Kothrud, Bibwewadi, Kasba Peth and Hadapsar), Nashik and Karad areas. Sahyadri has more than 1000 clinicians along with 2300 supporting staff providing latest medical services.

Sameer Sain, CEO, Everstone Group, said, “Sahyadri Hospitals is a reputed name for quality healthcare and will act as the anchor asset of our healthcare delivery platform. Everstone will leverage its’ significant healthcare expertise and experience to grow the overall business. We look forward to working closely with our partners and stakeholders.”

Commenting on the investment, Dr. Charudutt Apte, Founder, Chairman and MD, Sahyadri Hospitals said, “We are excited about this partnership and the value Everstone Group brings. Sahyadri Hospitals looks forward to the next phase of growth with the support of the experienced team at Everstone.”

According to industry estimates, private secondary and tertiary healthcare delivery in India is expected to grow from USD 42 bn in 2018 to USD 65 bn by 2022 at a CAGR of ~12%. This investment will help Sahyadri to cement its position as the leading healthcare chain in Maharashtra.

Everstone is one of the largest India and South East Asia focused healthcare investor specializing in rolling up assets within their platforms. In 2015, Everstone successfully exited Global Hospitals, a large multi-specialty tertiary hospital chain, generating strong returns. Everstone’s healthcare portfolio includes controlling stakes in domestic pharma distribution platform, Ascent Health; South East Asia based diagnostic device platform Everlife and an investment in one of the largest nutraceutical ingredient business, OmniActive. Everstone recently announced its successful exit from Rubicon Research (Rubicon) generating returns of 4.5x.

About Everstone Group
Everstone is a premier investment group focused on India and South East Asia, with assets in excess of US$5 billion across private equity, real estate, green infrastructure and venture capital. Everstone has a significant resource base across its seven offices in Singapore, India (Mumbai, Delhi, Bangalore), London, New York and Mauritius, comprising best-of-breed investing, operations and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com
LinkedIn

About Sahyadri Hospitals
Sahyadri Hospitals is the largest chain of hospitals in Maharashtra with 8 hospitals across three cities of Pune, Nashik and Karad. The hospital chain has over 900 Beds, 1,200 Clinicians and 2,300 Support Staff providing round the clock healthcare.
To know more: www.sahyadrihospital.com

READ MORE